{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:22Z","timestamp":1794017242346,"version":"4.8.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), leads to significant kidney inflammation and damage and drastically increases mortality risk. Predominantly impacting women in their reproductive years, LN poses specific risks during pregnancy, including pre-eclampsia, growth restrictions, stillbirth, and preterm delivery, exacerbated by lupus activity, specific antibodies, and pre-existing conditions like hypertension. Effective management of LN during pregnancy is crucial and involves carefully balancing disease control with the safety of the fetus. This includes pre-conception counseling and a multidisciplinary approach among specialists to navigate the complexities LN patients face during pregnancy, such as distinguishing LN flare-ups from pregnancy-induced conditions. This review focuses on exploring the complex dynamics between pregnancy and LN, emphasizing the management difficulties and the heightened risks pregnant women with LN encounter.<\/jats:p>","DOI":"10.3389\/fneph.2024.1390783","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:48:25Z","timestamp":1717480105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Lupus nephritis: management challenges during pregnancy"],"prefix":"10.3389","volume":"4","author":[{"given":"Zohreh","family":"Gholizadeh Ghozloujeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayna","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42375","article-title":"Incidence, prevalence, and mortality of lupus nephritis: A population-based study over four decades using the lupus midwest network","volume":"75","author":"Hocao\u011flu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Med (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01118-X","article-title":"Demographic differences in the development of lupus nephritis: a retrospective analysis","volume":"112","author":"Seligman","year":"2002","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24130","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000457967","article-title":"The impact of kidney development on the life course: A consensus document for action","volume":"136","author":"Brenner","year":"2017","journal-title":"Nephron"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.11431116","article-title":"Kidney outcomes and risk factors for nephritis (Flare\/de novo) in a multiethnic cohort of pregnant patients with lupus","volume":"12","author":"Buyon","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-020-2139-9","article-title":"Low frequency of flares during pregnancy and post-partum in stable lupus patients","volume":"22","author":"Davis-Porada","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex374","article-title":"An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus","volume":"57","author":"Teng","year":"2018","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23102","article-title":"Disease activity during pregnancy and the first year postpartum in women with systemic lupus erythematosus","volume":"69","author":"G\u00f6testam Skorpen","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0222343","DOI":"10.1371\/journal.pone.0222343","article-title":"Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia","volume":"14","author":"Shaharir","year":"2019","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.12441211","article-title":"Obstetric nephrology: lupus and lupus nephritis in pregnancy","volume":"7","author":"Stanhope","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319846650","article-title":"Pregnancy outcome in women with active and inactive lupus nephritis: A prospective cohort study","volume":"28","author":"Attia","year":"2019","journal-title":"Lupus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13075-015-0702-6","article-title":"Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research","volume":"17","author":"Mikdashi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B17","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20623","article-title":"Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SLICC\/ACR DI; SDI)","author":"Lattanzi","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1759720X211073001","DOI":"10.1177\/1759720x211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskeletal Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3366-y","article-title":"Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population","volume":"35","author":"Mej\u00eda-Vilet","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2891","DOI":"10.1097\/md.0000000000002891","article-title":"Characterization of patients with lupus nephritis included in a large cohort from the spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)","volume":"95","author":"Galindo-Izquierdo","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319890007","article-title":"Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine","volume":"29","author":"Lee","year":"2020","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.007","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000414","article-title":"Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus","volume":"29","author":"Izmirly","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000602","article-title":"Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes","volume":"9","author":"Balevic","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1715140","article-title":"New benefits of hydroxychloroquine in pregnant women with systemic lupus erythematosus: A retrospective study in a tertiary centre","volume":"42","author":"Abd Rahman","year":"2020","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"Jama"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e000714","DOI":"10.1136\/lupus-2022-000714","article-title":"Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study","volume":"9","author":"Tani","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40268-022-00408-0","article-title":"Benefits of hydroxychloroquine combined with low-dose aspirin on pregnancy outcomes and serum cytokines in pregnant women with systemic lupus erythematosus","volume":"23","author":"Zhang","year":"2023","journal-title":"Drugs R&D"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12192","article-title":"Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study","volume":"120","author":"Nezvalov\u00e1-Henriksen","year":"2013","journal-title":"BJOG: Int J Obstetrics Gynaecology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J obstetrics gynecology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Cleary","year":"2009","journal-title":"Birth Defects Res Part A: Clin Mol Teratology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/bmj.322.7298.1365","article-title":"Risk of miscarriage in pregnant users of NSAIDs: more information is needed to be able to interpret study's results","volume":"322","author":"Chan","year":"2001","journal-title":"BMJ: Br Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"Cmaj"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1284227","article-title":"Indomethacin in pregnancy: applications and safety","volume":"29","author":"Abou-Ghannam","year":"2011","journal-title":"Am J Perinatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G428","article-title":"Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis","volume":"40","author":"Koren","year":"2006","journal-title":"Ann Pharmacotherapy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2000.278.6.R1496","article-title":"Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo","volume":"278","author":"Takahashi","year":"2000","journal-title":"Am J physiology-Regulatory Integr Comp Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/uog.21997","article-title":"Safety of non-steroidal anti-inflammatory drugs in postpartum period in women with hypertensive disorders of pregnancy: systematic review and meta-analysis","volume":"56","author":"Bellos","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0040-1713180","article-title":"Postpartum NSAID use and adverse outcomes among women with hypertensive disorders of pregnancy: A systematic review and meta-analysis","volume":"38","author":"Premkumar","year":"2021","journal-title":"Am J Perinatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20422","article-title":"Patterns of medication use during pregnancy in rheumatoid arthritis","volume":"63","author":"Kuriya","year":"2011","journal-title":"Arthritis Care Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis rheumatism"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02699-1","article-title":"Preterm birth is strongly affected by the glucocorticoid dose during pregnancy in women complicated by systemic lupus erythematosus","volume":"24","author":"Shimada","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/gut.2010.222893","article-title":"Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study","volume":"60","author":"Coelho","year":"2011","journal-title":"Gut"},{"key":"B50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res Part A: Clin Mol Teratology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1977","article-title":"Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data","volume":"8","author":"Chambers","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis1","volume":"71","author":"Oz","year":"2001","journal-title":"Transplantation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Saf"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.3390\/jcm10214832","article-title":"Old and new calcineurin inhibitors in lupus nephritis","volume":"10","author":"Ponticelli","year":"2021","journal-title":"J Clin Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318770536","article-title":"The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus","volume":"27","author":"Ichinose","year":"2018","journal-title":"Lupus"},{"key":"B56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00565.x","article-title":"Outcomes of severe pre-eclampsia\/eclampsia in Yorkshire 1999\/2003","volume":"112","author":"Tuffnell","year":"2005","journal-title":"BJOG: Int J Obstetrics Gynaecology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling","year":"2019","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.644","article-title":"Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis","volume":"8","author":"Buawangpong","year":"2020","journal-title":"Pharmacol Res Perspectives"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.01.010","article-title":"Glomerular disease in women","volume":"3","author":"Wiles","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2020.08.001","article-title":"Glomerular disease and pregnancy","volume":"27","author":"Gleeson","year":"2020","journal-title":"Adv Chronic Kidney Disease"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids","volume":"72","author":"Condon","year":"2013","journal-title":"Ann rheumatic diseases"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/271363","article-title":"Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development","volume":"2008","author":"Klink","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu369","article-title":"Belimumab after rituximab as maintenance therapy in lupus nephritis","volume":"53","author":"Kraaij","year":"2014","journal-title":"Rheumatology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/art.38037","article-title":"Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study","volume":"65","author":"Mysler","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"B66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann rheumatic diseases"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.10060","article-title":"Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway","volume":"67","author":"Vaux","year":"2003","journal-title":"Birth Defects Res Part A: Clin Mol Teratology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042915-102658","article-title":"Management of systemic lupus erythematosus during pregnancy","volume":"68","author":"Sammaritano","year":"2017","journal-title":"Annu Rev Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000003755","article-title":"Rheumatologic medication use during pregnancy","volume":"135","author":"Peterson","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_4.50","article-title":"Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B71","year":"2013"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04682-3","article-title":"The effect of lupus disease on the pregnant women and embryos: a retrospective study from 2010 to 2014","volume":"38","author":"Rajaei","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1096-9926","article-title":"Teratogen update: Reproductive risks of leflunomide(Arava\u2122); A pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child","volume":"63","author":"Brent","year":"2001","journal-title":"Teratology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"101860","DOI":"10.1016\/j.berh.2023.101860","article-title":"Pregnancy in systemic lupus erythematosus","volume":"16","author":"Zucchi","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224242","article-title":"SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy","volume":"82","author":"Zhao","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002686","article-title":"Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I\/II trial","volume":"8","author":"Wang","year":"2022","journal-title":"RMD Open"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2007.01.003","article-title":"The Hopkins Lupus Pregnancy Center: ten key issues in management","volume":"33","author":"Petri","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2006.04.003","article-title":"Systemic lupus erythematosus and pregnancy","volume":"20","author":"Khamashta","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2022-1135","article-title":"Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes","volume":"50","author":"Crisafulli","year":"2023","journal-title":"J Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-021-02522-x","article-title":"Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus","volume":"23","author":"Hiramatsu","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/ijwh.S282604","article-title":"Systemic lupus erythematosus management in pregnancy","volume":"14","author":"Dao","year":"2022","journal-title":"Int J Womens Health"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/oarrr.S87828","article-title":"Management of systemic lupus erythematosus during pregnancy: challenges and solutions","volume":"9","author":"Knight","year":"2017","journal-title":"Open Access Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2017.05.006","article-title":"Lupus nephritis and pregnancy: concerns and management","volume":"37","author":"Lightstone","year":"2017","journal-title":"Semin Nephrol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.029","article-title":"Glomerular diseases in pregnancy: pragmatic recommendations for clinical management","volume":"103","author":"Fakhouri","year":"2023","journal-title":"Kidney Int"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2015.1033404","article-title":"Immunosuppression in pregnant women with systemic lupus erythematosus","volume":"11","author":"Ponticelli","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12884-021-04152-2","article-title":"Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study","volume":"21","author":"Takahashi","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynecology Obstetrics"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/tcrm.S160760","article-title":"Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis","volume":"14","author":"Wu","year":"2018","journal-title":"Ther Clin Risk Manage"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2147\/ijwh.S90157","article-title":"Systemic lupus erythematosus: strategies to improve pregnancy outcomes","volume":"8","author":"Yamamoto","year":"2016","journal-title":"Int J Womens Health"},{"key":"B95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13730-018-0373-7","article-title":"Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy","volume":"8","author":"Hirashima","year":"2019","journal-title":"CEN Case Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100724","article-title":"Approach to pregnancy in patients with lupus nephritis","volume":"5","author":"Tan","year":"2023","journal-title":"Kidney Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/hypertensionaha.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01448-1","article-title":"Postnatal care of woman with rheumatic diseases","volume":"37","author":"Mouyis","year":"2020","journal-title":"Adv Ther"},{"key":"B99","volume-title":"Drugs and lactation database (LactMed\u00ae)","year":"2023"},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00508-019-1448-y","article-title":"Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation","volume":"131","author":"Puchner","year":"2019","journal-title":"Wien Klin Wochenschr"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315583542","article-title":"Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature","volume":"24","author":"Campise","year":"2015","journal-title":"Lupus"},{"key":"B102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-6143.2003.30107.x","article-title":"Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses","volume":"3","author":"McGrory","year":"2003","journal-title":"Am J Transplantation"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.08.007","article-title":"Lupus nephritis and kidney transplantation: where are we today","volume":"26","author":"Wong","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43388","article-title":"Analysis of cardiovascular complications during delivery admissions among patients with systemic lupus erythematosus, 2004-2019","volume":"5","author":"Zahid","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000024","article-title":"Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus","volume":"1","author":"Lin","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2020-0028","article-title":"Pregnancy and dialysis","volume":"42","author":"Ribeiro","year":"2020","journal-title":"J Bras Nefrol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2007.01.017","article-title":"Pregnancy in patients on chronic dialysis: a single center experience and combined analysis of reported results","volume":"136","author":"Chou","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.01.010","article-title":"End-stage renal disease and pregnancy","volume":"20","author":"Nadeau-Fredette","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv016","article-title":"Pregnancy in end-stage renal disease patients on dialysis: how to achieve a successful delivery","volume":"8","author":"Manisco","year":"2015","journal-title":"Clin Kidney J"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2024.1390783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T16:33:47Z","timestamp":1718728427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2024.1390783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":109,"alternative-id":["10.3389\/fneph.2024.1390783"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2024.1390783","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"article-number":"1390783"}}